Skip to main content

Medication & Treatment

People with diabetes use many medications to both manage blood sugar levels and also to prevent or treat health complications.

For people with type 1 diabetes, the most important drug is insulin; some people with type 2 diabetes also take insulin. For people with type 2 diabetes, glucose-lowering medications include metformin, sulfonylureas, TZDs, SGLT-2 inhibitors, GLP-1 agonists, DPP-4 inhibitors, and more.

Some of these drugs are injected, others are taken in pill form, and some are even inhaled. Learn about the different treatment options available and which might be best for your lifestyle.

Metformin
Insulin
SGLT-2 inhibitors
GLP-1 agonists
DPP-4 inhibitors
Combination drugs
Sulfonylureas (SFUs)
TZDs

What's new

You may have heard about Semglee and Rezvoglar, popular alternatives for Lantus insulin; these are “biosimilars.” But what is a biosimilar? How is it different from a generic drug? Find answers to these questions and some tips on how to discuss biosimilars with your healthcare provider. Continue Reading »

Mounjaro (tirzepatide), a first-of-its kind medication for treating type 2 diabetes, has been approved by the FDA after much anticipation. This new medication has been shown to dramatically lower A1C and weight in clinical trials. Continue Reading »

Learn what some of the latest research says about the heart health benefits of diabetes drugs like SGLT-2 inhibitors, GLP-1 receptor agonists, and non-steroidal MRAs. Continue Reading »

Clinical trial results published by Lilly show that Tirzepatide could potentially be one of the most effective drugs ever developed for weight loss. Experts discuss these results and more at the ATTD 2022 conference in Barcelona, Spain. Continue Reading »

​For the first time, Time in Range was used as the main outcome measured in a clinical trial for a diabetes medication. Read about the study results and implications. Continue Reading »

once weekly insulin with semaglutide GLP-1 clinical trial

Learn more about how you can participate in this clinical trial from Novo Nordisk, testing whether a new once-weekly insulin injection, when combined with semaglutide, can help people with type 2 diabetes better manage their glucose levels and lose weight.  Continue Reading »

The diaTribe team is excited to cover all the latest news in diabetes technology and treatments, attending our first in-person diabetes conference in over two years! Find out what sessions and presenters we are most excited to see. Continue Reading »

Metformin is the world’s most common diabetes medication and can improve diabetes management. Research suggests that metformin might lead to weight loss in certain people – read more to learn about this common claim.  Continue Reading »

Pages